Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JADE study of JAQBO versus esomeprazole for healing ESD-induced gastric artificial ulcers
KCT0011616Phase 4Recruiting
- Sponsor
- Jeil Pharmaceutical Co., Ltd.
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in gastric ulcer and gastric cancer (GC) comparing JAQBO arm with Esomeprazole arm (2 arms). Primary endpoint: Upper gastrointestinal endoscopic healing rate at 4 weeks. Started Apr 2026; status: recruiting.
02
Drugs
zastaprazanesomeprazole
03
Conditions
gastric ulcergastric cancer (GC)
Beyond the preview
Go deeper on KCT0011616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0011616.